25 studies found for:    artificial Pancreas Outpatient
Show Display Options
Rank Status Study
1 Completed
Has Results
Artificial Pancreas Control System in an Outpatient Setting
Condition: Type 1 Diabetes Mellitus
Intervention: Device: Artificial Pancreas Control Software
2 Active, not recruiting Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home
Condition: Type 1 Diabetes
Interventions: Device: MD-Logic Artificial Pancreas (MDLAP) system;   Procedure: sensor augmented pump therapy
3 Completed
Has Results
Outpatient Control-to-Range: System and Monitoring Testing
Condition: Type 1 Diabetes Mellitus
Intervention: Device: Outpatient Control-to-Range
4 Active, not recruiting Outpatient Control-to-Range: System and Monitoring Testing
Condition: Type 1 Diabetes Mellitus
Intervention: Device: DiAs Diabetes Assistant Wearable Artificial Pancreas Platform
5 Recruiting MMPPC: A Probabilistic Closed-loop Artificial Pancreas to Handle Unannounced Meals and Exercise
Condition: Type 1 Diabetes
Interventions: Device: Inpatient use of the MMPPC/DiAs system;   Device: Outpatient use of the MMPPC/DiAs system
6 Recruiting Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Condition: Diabetes Mellitus, Type 1
Interventions: Device: CGM and Insulin Pump;   Device: Closed-Loop Control System
7 Completed Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing
Condition: Type 1 Diabetes Mellitus
Intervention: Device: portable artificial pancreas system with CTR algorithms
8 Completed Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova
Condition: Type 1 Diabetes Mellitus
Intervention: Device: Portable artificial pancreas system with Control-To-Range
9 Completed Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier
Condition: Type 1 Diabetes Mellitus
Intervention: Device: portable artificial pancreas system with Control-To-Range algorithms
10 Active, not recruiting Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use
Condition: Type 1 Diabetes
Intervention: Device: Closed-Loop Control System
11 Active, not recruiting Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas
Condition: Type 1 Diabetes
Interventions: Device: Bi-homonal Bionic Pancreas;   Other: Usual care
12 Completed Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (Italy)
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Diabetes Assistant (DiAs)
13 Completed Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (France)
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Diabetes Assistant (DiAs)
14 Completed
Has Results
Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Diabetes Assistant (DiAs)
15 Active, not recruiting The Summer Camp Study 2:Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas
Condition: Type 1 Diabetes
Interventions: Device: Bi-hormonal Bionic Pancreas;   Other: Usual Care
16 Active, not recruiting The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas
Condition: Type 1 Diabetes
Interventions: Device: Bi-hormonal Bionic Pancreas;   Other: Usual Care
17 Completed
Has Results
Artificial Pancreas Control System in an Inpatient Setting
Condition: Type I Diabetes Mellitus
Intervention: Device: Artificial Pancreas Control Software
18 Completed MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management
Condition: Type 1 Diabetes
Interventions: Device: MD-bolus calculator for pre-meal bolus;   Device: No MD-bolus calculator for pre-meal bolus
19 Recruiting Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 15-hour intervention;   Drug: Insulin (Lispro, Aspart or guilisine);   Drug: Glucagon (Eli Lilly);   Other: Closed-loop strategy
20 Recruiting Closed-Loop Glucagon Administration For Hypoglycemia Treatment
Condition: Type 1 Diabetes
Intervention: Device: Glucagon-only Bionic Pancreas

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years